Monday - February 16, 2026

Liposarcoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Liposarcoma Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Liposarcoma pipeline landscape. It covers the Liposarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Liposarcoma pipeline therapeutics … Continue reading

Nasopharyngeal Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Nasopharyngeal Cancer Pipeline Insight” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Nasopharyngeal Cancer pipeline landscape. It covers the Nasopharyngeal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Nasopharyngeal … Continue reading

Oligonucleotide Synthesis Market worth $19.7 billion by 2029 | MarketsandMarkets™

The North American market is projected to grow at the highest CAGR during the Forecast Oligonucleotide Synthesis Market Size by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents, Equipment), Type (Custom, Predesigned), Application (Therapeutic (Neurology, Rare), Research (PCR, Sequencing), Diagnostics) … Continue reading

Adrenocortical Carcinoma Treatment Market Size in the 7MM reached approximately ~USD 22.4 million in 2023, is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Adrenocortical Carcinoma Market Insights, Epidemiology, and Market Forecast-2034” report offers an in-depth understanding of Adrenocortical Carcinoma, including historical and forecasted epidemiology, as well as Adrenocortical Carcinoma market trends in the United States, EU4 (Germany, Spain, Italy, France), the United … Continue reading